The Need For New Treatment Regimens In Older Aml Patients

The need for new treatment regimens in older AML patients

VJHemOnc – Video Journal of Hematology & HemOnc

Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 2

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

Decitabine dosing regimens in older AML patients: 5-day vs. 10-day, is there a difference?

VJHemOnc – Video Journal of Hematology & HemOnc

Treating older patients with AML in 2020: What is new and promising?

ASH Clinical Practice Guidelines on Acute Myeloid Leukemia (AML) In Older Adults

American Society of Hematology

The development of clinical guidelines for older patients with AML

VJHemOnc – Video Journal of Hematology & HemOnc

Novel treatments of AML in elderly patients

VJHemOnc – Video Journal of Hematology & HemOnc

The complications of treating elderly patients with AML

VJHemOnc – Video Journal of Hematology & HemOnc

Managing AML in elderly patients

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment cessation using venetoclax-based therapy for older patients with AML

VJHemOnc – Video Journal of Hematology & HemOnc

A new era of treatment for elderly acute myeloid leukemia (AML) patients?

VJHemOnc – Video Journal of Hematology & HemOnc

Novel approaches to treating AML in elderly patients

VJHemOnc – Video Journal of Hematology & HemOnc

What are the leading clinical trials in older patients with AML?

Recent Data on the Treatment of Older Patients With AML

Treating Acute Myeloid Leukemia (AML) in Older Adults

A new era for elderly AML patients

VJHemOnc – Video Journal of Hematology & HemOnc

Management of Older Patients with AML

International Academy for Clinical Hematology IACH

Treating AML In Older Adults

Treatment approaches for elderly/unfit patients with AML ineligible for intensive chemotherapy

VJHemOnc – Video Journal of Hematology & HemOnc